CA2300703A1 - Method for treating excessive sweating - Google Patents
Method for treating excessive sweating Download PDFInfo
- Publication number
- CA2300703A1 CA2300703A1 CA002300703A CA2300703A CA2300703A1 CA 2300703 A1 CA2300703 A1 CA 2300703A1 CA 002300703 A CA002300703 A CA 002300703A CA 2300703 A CA2300703 A CA 2300703A CA 2300703 A1 CA2300703 A1 CA 2300703A1
- Authority
- CA
- Canada
- Prior art keywords
- excessive sweating
- botulinum toxin
- treating
- secretions
- treating excessive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000035900 sweating Effects 0.000 title abstract 2
- 108030001720 Bontoxilysin Proteins 0.000 abstract 2
- 229940053031 botulinum toxin Drugs 0.000 abstract 2
- 230000028327 secretion Effects 0.000 abstract 2
- 206010023644 Lacrimation increased Diseases 0.000 abstract 1
- 208000007101 Muscle Cramp Diseases 0.000 abstract 1
- 208000029578 Muscle disease Diseases 0.000 abstract 1
- 208000021642 Muscular disease Diseases 0.000 abstract 1
- 208000005392 Spasm Diseases 0.000 abstract 1
- 210000002565 arteriole Anatomy 0.000 abstract 1
- 230000001713 cholinergic effect Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000002526 effect on cardiovascular system Effects 0.000 abstract 1
- 210000000232 gallbladder Anatomy 0.000 abstract 1
- 210000005095 gastrointestinal system Anatomy 0.000 abstract 1
- 230000004317 lacrimation Effects 0.000 abstract 1
- 210000003097 mucus Anatomy 0.000 abstract 1
- 230000004118 muscle contraction Effects 0.000 abstract 1
- 210000000664 rectum Anatomy 0.000 abstract 1
- 210000002460 smooth muscle Anatomy 0.000 abstract 1
- 210000005070 sphincter Anatomy 0.000 abstract 1
- 230000002485 urinary effect Effects 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention provides a method for relieving pain, associated with muscle contractions, a composition and a method of treating conditions such as cholinergic controlled secretions including excessive sweating, lacrimation and mucus secretions and a method for treating smooth muscle disorders including, but not limited to, spasms in the sphincter of the cardiovascular arteriole, gastrointestinal system, urinary, gall bladder and rectum, which method comprises administering to the patient suffering from said disorder or condition a therapeutically effective amount of Botulinum toxin selected from a group consisting of Botulinum toxin types B, C, D, E, F and G.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17399693A | 1993-12-28 | 1993-12-28 | |
| US08/173,996 | 1993-12-28 | ||
| CA002180011A CA2180011C (en) | 1993-12-28 | 1994-12-16 | Botulinum toxins for treating sweating |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002180011A Division CA2180011C (en) | 1993-12-28 | 1994-12-16 | Botulinum toxins for treating sweating |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2300703A1 true CA2300703A1 (en) | 1995-07-06 |
| CA2300703C CA2300703C (en) | 2001-12-11 |
Family
ID=25678525
Family Applications (10)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002300451A Abandoned CA2300451A1 (en) | 1993-12-28 | 1994-12-16 | Method for treating a pyloric valve disease |
| CA002300723A Abandoned CA2300723A1 (en) | 1993-12-28 | 1994-12-16 | Method for treating pain associated with a muscle disorder |
| CA002300386A Expired - Fee Related CA2300386C (en) | 1993-12-28 | 1994-12-16 | Method for treating dystonia with botulinum toxin types c,d and e |
| CA002300464A Expired - Fee Related CA2300464C (en) | 1993-12-28 | 1994-12-16 | Method for treating headache |
| CA002300663A Expired - Fee Related CA2300663C (en) | 1993-12-28 | 1994-12-16 | Method for treating dysphagia |
| CA002300433A Abandoned CA2300433A1 (en) | 1993-12-28 | 1994-12-16 | Method for treating a lacrimation disorder |
| CA002300703A Expired - Lifetime CA2300703C (en) | 1993-12-28 | 1994-12-16 | Method for treating excessive sweating |
| CA002300771A Abandoned CA2300771A1 (en) | 1993-12-28 | 1994-12-16 | Method for treating a mucus secretion |
| CA002300766A Expired - Lifetime CA2300766C (en) | 1993-12-28 | 1994-12-16 | Neurotoxic component of botulinum toxin for treating cervical dystonia |
| CA002300666A Expired - Lifetime CA2300666C (en) | 1993-12-28 | 1994-12-16 | Method for treating dystonia with botulinum toxin type b |
Family Applications Before (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002300451A Abandoned CA2300451A1 (en) | 1993-12-28 | 1994-12-16 | Method for treating a pyloric valve disease |
| CA002300723A Abandoned CA2300723A1 (en) | 1993-12-28 | 1994-12-16 | Method for treating pain associated with a muscle disorder |
| CA002300386A Expired - Fee Related CA2300386C (en) | 1993-12-28 | 1994-12-16 | Method for treating dystonia with botulinum toxin types c,d and e |
| CA002300464A Expired - Fee Related CA2300464C (en) | 1993-12-28 | 1994-12-16 | Method for treating headache |
| CA002300663A Expired - Fee Related CA2300663C (en) | 1993-12-28 | 1994-12-16 | Method for treating dysphagia |
| CA002300433A Abandoned CA2300433A1 (en) | 1993-12-28 | 1994-12-16 | Method for treating a lacrimation disorder |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002300771A Abandoned CA2300771A1 (en) | 1993-12-28 | 1994-12-16 | Method for treating a mucus secretion |
| CA002300766A Expired - Lifetime CA2300766C (en) | 1993-12-28 | 1994-12-16 | Neurotoxic component of botulinum toxin for treating cervical dystonia |
| CA002300666A Expired - Lifetime CA2300666C (en) | 1993-12-28 | 1994-12-16 | Method for treating dystonia with botulinum toxin type b |
Country Status (1)
| Country | Link |
|---|---|
| CA (10) | CA2300451A1 (en) |
-
1994
- 1994-12-16 CA CA002300451A patent/CA2300451A1/en not_active Abandoned
- 1994-12-16 CA CA002300723A patent/CA2300723A1/en not_active Abandoned
- 1994-12-16 CA CA002300386A patent/CA2300386C/en not_active Expired - Fee Related
- 1994-12-16 CA CA002300464A patent/CA2300464C/en not_active Expired - Fee Related
- 1994-12-16 CA CA002300663A patent/CA2300663C/en not_active Expired - Fee Related
- 1994-12-16 CA CA002300433A patent/CA2300433A1/en not_active Abandoned
- 1994-12-16 CA CA002300703A patent/CA2300703C/en not_active Expired - Lifetime
- 1994-12-16 CA CA002300771A patent/CA2300771A1/en not_active Abandoned
- 1994-12-16 CA CA002300766A patent/CA2300766C/en not_active Expired - Lifetime
- 1994-12-16 CA CA002300666A patent/CA2300666C/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2300766A1 (en) | 1995-07-06 |
| CA2300433A1 (en) | 1995-07-06 |
| CA2300771A1 (en) | 1995-07-06 |
| CA2300703C (en) | 2001-12-11 |
| CA2300666C (en) | 2002-04-30 |
| CA2300464A1 (en) | 1995-07-06 |
| CA2300666A1 (en) | 1995-07-06 |
| CA2300464C (en) | 2001-12-11 |
| CA2300386A1 (en) | 1995-07-06 |
| CA2300663A1 (en) | 1995-07-06 |
| CA2300451A1 (en) | 1995-07-06 |
| CA2300386C (en) | 2002-04-23 |
| CA2300766C (en) | 2008-10-14 |
| CA2300663C (en) | 2003-05-06 |
| CA2300723A1 (en) | 1995-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2180011A1 (en) | Botulinum toxins for treating sweating | |
| WO1995017904B1 (en) | Botulinum toxins for treating various disorders and associated pain | |
| CA2164866A1 (en) | Treatment of neuromuscular disorders and conditions with different botulinum serotype | |
| CA2190011A1 (en) | Method for Reduction of Headache Pain | |
| CA2164626A1 (en) | Multiple botulinum toxins for treating neuromuscular disorders and conditions | |
| EP2145629A3 (en) | Use of neurotoxin therapy for treatment of urologic and related disorders | |
| JP2004518632A5 (en) | ||
| EP0433299A4 (en) | Treatment of gastro-intestinal disorders | |
| CA2164291A1 (en) | Methods and pharmaceutical compositions useful for treating neurological disorders | |
| GB9205800D0 (en) | Treatment of fibrotic disorders | |
| MY118526A (en) | Method for improving the pharmacokinetics of tipranavir | |
| CA2061665A1 (en) | Treatment of lower urinary tract disorders | |
| CA2275167A1 (en) | The topical use of kappa opioid agonists to treat ocular pain | |
| WO2002039999B1 (en) | Use of suramine, l-histidine, quisqualic acid or d-cycloserine for angiogenesis inhibition | |
| CA2136953A1 (en) | A method for using lipoprotein associated coagulation inhibitor to treat sepsis | |
| CA2300703A1 (en) | Method for treating excessive sweating | |
| CA2589987A1 (en) | Method for treating a cholinergic influenced secretion | |
| 张安莉 et al. | Clinical effect of acupuncture in the treatment of gastrokinetic disturbance | |
| WO1998001125A3 (en) | Dextrorotatory isomers of oxybutynin and desethyloxybutynin in the treatment of gastrointestinal hyperactivity | |
| CA2248753A1 (en) | Use of olanzapine for treating excessive aggression | |
| CA2149766A1 (en) | Rectal flunisolide compositions for treating inflammatory intestinal disorders | |
| WO1996029076A3 (en) | Treatment of inflammatory bowel disorders with cotinine | |
| CA2219603A1 (en) | Method of stimulating gastrointestinal motility with ellagic acid | |
| CA2561293A1 (en) | Treatment of incontinence | |
| EP1712231A3 (en) | Method for improving the pharmacokinetics of tipranavir |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKEX | Expiry |
Effective date: 20141216 |